About
Roger Baker is a clinical psychologist and Professor at Bournemouth University, UK, with a career spanning over five decades. He is renowned for developing the Emotional Processing Scale (EPS-25) and leading multi-centre randomized controlled trials on fatigue management in multiple sclerosis. His research integrates cognitive behavioural therapy with emotional processing theory to address PTSD, panic disorder, and chronic illness.
Education: Specific degrees are not listed in the provided text; however, his long-standing academic and clinical roles imply doctoral-level training in clinical psychology.
Research Interests: Professor Baker’s work centres on emotional processing—how people perceive, interpret, and respond to emotional experiences. He investigates this mechanism across clinical populations, including those with PTSD, panic disorder, multiple sclerosis, and psychogenic non-epileptic seizures. His studies explore cross-cultural variations, scale validation, and therapeutic enhancement of emotional processing using CBT.
Publication Trends: Across 40+ years, Baker’s articles cluster into three dominant streams: (1) development and validation of the EPS-25 tool, (2) randomized trials of group-based CBT for MS-fatigue (FACETS programme), and (3) experimental and clinical studies linking emotional processing deficits to panic, trauma, and chronic disease. Recent works extend into medical procedures (colonoscopy pain) and cross-cultural re-validation of his scale.
Scientific Awards:
- Honorary Fellowship, British Association for Behavioural and Cognitive Psychotherapy (BABCP), 2015 – awarded for outstanding contribution to CBT.
Grants & Leadership: He has chaired the Social & Care Research Grant Committee of the UK Multiple Sclerosis Society and served on its Research Strategy Committee, indicating sustained grant leadership and policy influence.
Labs & Teams: While no specific lab name is given, Baker collaborates extensively with multi-disciplinary teams across neurology, health psychology, and nursing, coordinating multi-centre trials (FACETS) and international validation studies (France, Italy, Poland).
